Susanne Brakemeier

Everolimus for angiomyolipoma associated with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis (EXIST-2): a multicentre, randomised, double-blind, placebo-controlled trial

John J. Bissler, J.C. Kingswood, Elżbieta Radzikowska et al. · The Lancet · 2013 · 863 citations

Tuberous Sclerosis Complex, Sporadic Lymphangioleiomyomatosis, Pathology +4

Donor-Specific HLA Antibodies in a Cohort Comparing Everolimus With Cyclosporine After Kidney Transplantation

Lutz Liefeldt, Susanne Brakemeier, Petra Glander et al. · American Journal of Transplantation · 2012 · 237 citations · Full text

Blockade of the Intermediate-Conductance Calcium-Activated Potassium Channel as a New Therapeutic Strategy for Restenosis

Ralf Köhler, Heike Wulff, Ines Eichler et al. · Circulation · 2003 · 235 citations

Selective blockade of endothelial Ca²⁺‐activated small‐ and intermediate‐conductance K⁺‐channels suppresses EDHF‐mediated vasodilation

Ines Eichler, Judith Wibawa, Ivica Grgic et al. · British Journal of Pharmacology · 2003 · 170 citations · Full text

Everolimus long-term use in patients with tuberous sclerosis complex: Four-year update of the EXIST-2 study

John J. Bissler, J.C. Kingswood, Elżbieta Radzikowska et al. · PLoS ONE · 2017 · 162 citations · Full text